BRIEF-Johnson & Johnson reports 15 pct passive stake in Protagonist Therapeutics - SEC filing

* Johnson & Johnson reports 15.0 pct passive stake in

Protagonist Therapeutics Inc as of Aug. 16

Source text (http://bit.ly/2biMrcb)

Further company coverage:

Read more